|Titre :||Prospective study on factors associated with referral of patients with opioid maintenance therapy from specialized addictive disorders centers to primary care (2021)|
|Auteurs :||M. GUILLOU-LANDREAT ; P. LEVASSOR ; M. GUERLAIS ; V. SEBILLE ; C. VICTORRI-VIGNEAU|
|Type de document :||Article : Périodique|
|Dans :||International Journal of Environmental Research and Public Health (Vol.18, n°11, June 2021)|
|Article en page(s) :||art. 5749|
|Discipline :||TRA (Traitement et prise en charge / Treatment and care)|
Thésaurus TOXIBASEETUDE PROSPECTIVE ; TRAITEMENT DE MAINTENANCE ; OPIACES ; OPIOIDES ; METHADONE ; BUPRENORPHINE ; ORIENTATION ; DISPOSITIF DE SOIN ; CSAPA ; SOINS DE PREMIER RECOURS ; MEDECIN GENERALISTE ; SUIVI DU PATIENT ; OBSERVANCE DU TRAITEMENT ; QUALITE DE VIE
Background: One of the most important issues for opiate maintenance therapy efficacy is the involvement of primary care physicians (PCPs) in opiate use disorder treatment, especially after referral from specialized units. This study aimed to analyze the progress of subjects in a specialized center and after referral to PCPs.
Methods: This study was an observational prospective study. Recruitment took place in a specialized addictive disorder center in western France. All patients were evaluated (sociodemographical data, severity of substance use disorders through the TMSP scale, the quality of life through the TEAQV scale) by physicians during the 5-year-follow up of the study. Analysis focused on four main times during follow-up: entry/last visit into specialized care and into primary care.
Results: 113 patients were included in this study; 93% were receiving methadone and 7% buprenorphine. Ninety (90) were referred to primary care. In primary care follow-up, the probability of the lowest severity score for substance use disorders remained stable over time.
Conclusions: In daily practice, a center specialized in addictive disorders referred OMT management to PCPs for a majority of patients, and benefits regarding substance use disorders severity and quality of life remained stable after referral. Our results need to be confirmed.
|Domaine :||Autres substances / Other substances ; Drogues illicites / Illicit drugs|
INSERM UMR 1246, SPHERE, Methods in Patient-Centered Outcomes and Health Research, Nantes and Tours Universities, Nantes, France
CHU Nantes, Pharmacology Department, Nantes, France